Non-Operating Income/Expense (Quarterly)

Non-Operating Income/Expense: The sum of all non-operating expenses for the given industry.

MacroGenics, Inc. (MGNX) had Non-Operating Income/Expense of $-1.81M for the most recently reported fiscal quarter, ending 2025-09-30.

Quarterly Annual

Figures for fiscal quarter ending 2025-09-30

Income Statement Financials
Revenue	$72.84M
Net Income	$16.82M
Cost of Goods Sold	$11.59M
Gross Profit	$61.25M
Operating Expenses	$54.20M
Operating Income	$18.64M
Non-Operating Income/Expense	$-1.81M
Pre-Tax Income	$16.82M
Normalized Pre-Tax Income	$16.82M
Income after Taxes	$16.82M
Income from Continuous Operations	$16.82M
Consolidated Net Income/Loss	$16.82M
Normalized Income after Taxes	$16.82M
EBIT	$18.64M
EBITDA	$19.91M
Weighted-Average Shares Outstanding (Basic)	63.23M
Weighted-Average Shares Outstanding (Diluted)	63.28M
Earnings per Share (EPS) (Basic)	$0.27
Earnings per Share (EPS) (Diluted)	$0.27
Balance Sheet Financials
Current Assets	$232.09M
Property, Plant, and Equipment	$13.97M
Long-Term Assets	$38.67M
Total Assets	$270.76M
Current Liabilities	$44.47M
Long-Term Debt	--
Long-Term Liabilities	$159.29M
Total Liabilities	$203.76M
Common Equity	$67.00M
Tangible Shareholders Equity	$67.00M
Shareholders Equity	$67.00M
Common Shares Outstanding	63.26M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-124.06M
Cash Flow from Investing Activities	$-48.11M
Cash Flow from Financial Activities	$69.46M
Beginning Cash	$182.84M
End Cash	$80.13M
Increase/Decrease in Cash	$-102.71M
Stock-Based Compensation	$11.62M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	5.22
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	--
Debt to Equity Ratio	--
Gross Margin	84.09%
Operating Margin	25.59%
EBIT Margin	25.59%
EBITDA Margin	--
Pre-Tax Profit Margin	23.09%
Profit Margin	23.09%
Free Cash Flow	$-125.73M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.27
Inventory Turnover	1.32
Receiveable Turnover	1.05
Days Sales in Receivables	85.54
Return on Equity	25.11%
Return on Tangible Equity	25.11%
Return on Assets	6.21%
Return on Investments	25.11%
Book Value Per Share	$1.06
Free Cash Flow per Share	$-1.99
Operating Cash Flow per Share	$-1.96

Data from Zacks Investment Research, Inc.